Glassman Wealth Services Biomarin Pharmaceutical Inc Transaction History

Glassman Wealth Services

$542 Million
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$76.22 - $98.51 $12,195 - $15,761	-160 Reduced 78.82%	43 $4,000
Q3 2023 Nov 13, 2023	SELL	$85.07 - $94.48 $5,274 - $5,857	-62 Reduced 23.4%	203 $17,000
Q2 2023 Aug 08, 2023	BUY	$86.68 - $100.3 $86 - $100	1 Added 0.38%	265 $22,000
Q1 2023 May 04, 2023	BUY	$87.74 - $117.27 $701 - $938	8 Added 3.13%	264 $25,000
Q4 2022 Feb 06, 2023	BUY	$80.93 - $108.63 $728 - $977	9 Added 3.64%	256 $26,000
Q2 2022 Aug 04, 2022	SELL	$71.48 - $86.85 $6,218 - $7,555	-87 Reduced 26.05%	247 $20,000
Q1 2022 Aug 23, 2022	SELL	$74.28 - $92.69 $222 - $278	-3 Reduced 0.89%	334 $26,000
Q1 2022 Apr 14, 2022	BUY	$74.28 - $92.69 $4,531 - $5,654	61 Added 22.1%	337 $26,000
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $2,223 - $2,835	31 Added 12.65%	276 $24,000
Q3 2021 Nov 10, 2021	BUY	$74.77 - $85.47 $1,121 - $1,282	15 Added 6.52%	245 $19,000
Q2 2021 Aug 04, 2021	BUY	$75.51 - $84.79 $453 - $508	6 Added 2.68%	230 $19,000
Q1 2021 May 05, 2021	BUY	$74.73 - $90.69 $149 - $181	2 Added 0.9%	224 $17,000
Q4 2020 Feb 04, 2021	BUY	$72.61 - $90.2 $14,231 - $17,679	196 Added 753.85%	222 $19,000
Q3 2020 Nov 09, 2020	SELL	$71.87 - $131.03 $4,815 - $8,779	-67 Reduced 72.04%	26 $2,000
Q2 2020 Aug 06, 2020	BUY	$79.55 - $124.22 $5,329 - $8,322	67 Added 257.69%	93 $11,000
Q1 2020 May 12, 2020	BUY	$71.37 - $96.85 $1,284 - $1,743	18 Added 225.0%	26 $2,000
Q4 2019 Feb 07, 2020	BUY	$64.27 - $86.37 $514 - $690	8 New	8 $1,000
Q3 2019 Nov 01, 2019	SELL	$67.4 - $85.11 $3,370 - $4,255	-50 Closed	0 $0
Q2 2019 Aug 08, 2019	SELL	$80.35 - $93.9 $482 - $563	-6 Reduced 10.71%	50 $4,000
Q1 2019 May 10, 2019	BUY	$84.2 - $98.62 $4,041 - $4,733	48 Added 600.0%	56 $5,000
Q2 2018 Aug 09, 2018	BUY	$76.01 - $99.03 $304 - $396	4 Added 100.0%	8 $1,000
Q1 2018 May 01, 2018	BUY	$77.67 - $92.63 $310 - $370	4 New	4 $0

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

Black Rock Inc. New York, NY

22.7M
Shares

$1.6 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$1.34 Billion
0.03% of portfolio
Primecap Management CO Pasadena, CA

18.8M
Shares

$1.33 Billion
1.14% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$983 Million
0.72% of portfolio
Capital Research Global Investors Los Angeles, CA

9.69M
Shares

$684 Million
0.18% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Glassman Wealth Services with notifications on news.

Account